» Articles » PMID: 36144403

Trends in Occurrence and Phenotypic Resistance of Coagulase-Negative Staphylococci (CoNS) Found in Human Blood in the Northern Netherlands Between 2013 and 2019

Overview
Journal Microorganisms
Specialty Microbiology
Date 2022 Sep 23
PMID 36144403
Authors
Affiliations
Soon will be listed here.
Abstract

Background: For years, coagulase-negative staphylococci (CoNS) were not considered a cause of bloodstream infections (BSIs) and were often regarded as contamination. However, the association of CoNS with nosocomial infections is increasingly recognized. The identification of more than 40 different CoNS species has been driven by the introduction of matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Yet, treatment guidelines consider CoNS as a whole group, despite increasing antibiotic resistance (ABR) in CoNS. This retrospective study provides an in-depth data analysis of CoNS isolates found in human blood culture isolates between 2013 and 2019 in the entire region of the Northern Netherlands.

Methods: In total, 10,796 patients were included that were hospitalized in one of the 15 hospitals in the region, leading to 14,992 CoNS isolates for (ABR) data analysis. CoNS accounted for 27.6% of all available 71,632 blood culture isolates. EUCAST Expert rules were applied to correct for errors in antibiotic test results.

Results: A total of 27 different CoNS species were found. Major differences were observed in occurrence and ABR profiles. The top five species covered 97.1% of all included isolates: , , , and . Regarding ABR, methicillin resistance was most frequently detected in (72%), (65%), and (62%). and showed 50-80% resistance to teicoplanin and macrolides while resistance to these agents remained lower than 10% in most other CoNS species.

Conclusion: These differences are often neglected in national guideline development, prompting a focus on 'ABR-safe' agents such as glycopeptides. In conclusion, this multi-year, full-region approach to extensively assess the trends in both the occurrence and phenotypic resistance of CoNS species could be used for evaluating treatment policies and understanding more about these important but still too often neglected pathogens.

Citing Articles

The pathogenicity and virulence of the opportunistic pathogen .

Burke O, Zeden M, OGara J Virulence. 2024; 15(1):2359483.

PMID: 38868991 PMC: 11178275. DOI: 10.1080/21505594.2024.2359483.


Trends in coagulase-negative staphylococci (CoNS), England, 2010-2021.

Paranthaman K, Wilson A, Verlander N, Rooney G, MacDonald N, Nsonwu O Access Microbiol. 2023; 5(6).

PMID: 37424540 PMC: 10323795. DOI: 10.1099/acmi.0.000491.v3.


Leaky barriers to gene sharing between locally co-existing coagulase-negative Staphylococcus species.

Ikhimiukor O, Souza S, Marcovici M, Nye G, Gibson R, Andam C Commun Biol. 2023; 6(1):482.

PMID: 37137974 PMC: 10156822. DOI: 10.1038/s42003-023-04877-0.


A Comprehensive Study on Antibiotic Resistance among Coagulase-Negative Staphylococci (CoNS) Strains Isolated from Ready-to-Eat Food Served in Bars and Restaurants.

Chajecka-Wierzchowska W, Gajewska J, Zadernowska A, Randazzo C, Caggia C Foods. 2023; 12(3).

PMID: 36766043 PMC: 9914766. DOI: 10.3390/foods12030514.

References
1.
Lane M, Roy A, Kearney M, Pucheu-Haston C . Characterization, distribution, antimicrobial resistance and resistance risk factors in staphylococci isolated from cats from 2001 to 2014. Vet Med Sci. 2018; 4(4):315-325. PMC: 6236134. DOI: 10.1002/vms3.122. View

2.
Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

3.
Kleinschmidt S, Huygens F, Faoagali J, Rathnayake I, Hafner L . Staphylococcus epidermidis as a cause of bacteremia. Future Microbiol. 2015; 10(11):1859-79. DOI: 10.2217/fmb.15.98. View

4.
Wisplinghoff H, Rosato A, Enright M, Noto M, Craig W, Archer G . Related clones containing SCCmec type IV predominate among clinically significant Staphylococcus epidermidis isolates. Antimicrob Agents Chemother. 2003; 47(11):3574-9. PMC: 253785. DOI: 10.1128/AAC.47.11.3574-3579.2003. View

5.
Mihaila L, Defrance G, Levesque E, Ichai P, Garnier F, Derouin V . A dual outbreak of bloodstream infections with linezolid-resistant Staphylococcus epidermidis and Staphylococcus pettenkoferi in a liver Intensive Care Unit. Int J Antimicrob Agents. 2012; 40(5):472-4. DOI: 10.1016/j.ijantimicag.2012.06.014. View